HealthcareLarge capRs 28,523 crRs 34.4 cr traded a day
Close on 2026-08-21
1,724.70
−2.04%
52-week range94% of the way up
577.251,804.10
Market cap
28,523 cr
P/E (TTM)
99.0×
industry 44×
EPS (TTM)
17.43
Net margin
15.9%
1 month
+13.1%
Below 52w high
4.6%
RSI (14)
71
overbought
Daily swing
4.4%
average true range
Volume
0.7×
vs 20-day average
Traded
Rs 34 cr
median day
Close200-day averageMaterial filing
222 sessions · hover for the filing behind a move
1 week
+6.52%
1 month
+13.07%
3 months
+76.39%
6 months
+118.97%
1 year
—
The read
written from the numbers on this page
The evidence leans constructive6 supporting, 1 against, 0 worth knowing
Supporting
trading 76% above its 200-day average
sitting at 94% of its 52-week range, with little overhead supply from trapped buyers
matches stretched far above trend, which has beaten the market by +0.82 points over 20 sessions across 27,715 past signals
2 of the scans it matches have a positive measured record
3 independent kinds of evidence agree today, which is uncommon
net margin has widened from 13.1% to 15.9% across four quarters
Against
priced at 99× earnings against an industry median of 44× — 125% above its peers
Worth knowing
nothing the data supports either way
What would change this read: a close below 977, its 200-day average; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
How it has performed
price return over each window, measured against zero
What the scans say today
4 of 47 matched on 2026-08-21
RUBICON matches 4 of the 47 scans today, across 3 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
Analyst call filings were typically +0.14pt vs the market over the next 5 sessions (n=3,352) · Other filing filings were typically -0.08pt vs the market over the next 5 sessions (n=12,093) · Board meeting filings were typically -0.04pt vs the market over the next 5 sessions (n=5,458)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
net margin widened from 14.9% to 15.9%
revenue rose in 3 of the last 3 quarters
Going against it
nothing clear in the filed numbers
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · consolidated
534
110
85
5.13
15.9%
Q4 FY26
2026-03-31 · consolidated
514
99
77
4.66
14.9%
Q3 FY26
2025-12-31 · consolidated
476
91
73
4.46
15.3%
Q2 FY26
2025-09-30 · consolidated
412
72
54
3.49
13.1%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+15.5%
Versus 200-day average+76.5%
Below 52-week high-4.4%
Above 52-week low+198.8%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)70.8
Higher closes in last 52 of 5
Six-month return+118.97%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)4.42%
Volume versus 20-day0.7x
Median daily turnoverRs 34.4 cr
Peers
Healthcare · 67 classified companies
RUBICON trades at 99.0× trailing earnings against an industry median of 44.0× across 64 other classified companies in its industry — more expensive than them, by 125%. A multiple is a statement about expectations, not about quality: cheap usually means the market expects less, and it is often right.
largest twelve by market capitalisation. Market cap and P/E need filed financials, so blanks are companies whose filings have not been read yet
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.